Factors influencing the initiation and adherence of LTBI treatment in healthcare workers: a systematic review

References

• WHO. Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management. Geneva: World Health Organization; 2018:9241550236.
   Google Scholar
• Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10):e1002152. doi:10.1371/journal.pmed.1002152.
   PubMed Web of Science ®Google Scholar
• Sterling TR, Njie G, Zenner D, et al. Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020. Am J Transplant. 2020;20(4):1196–1206. doi:10.1111/ajt.15841.
   Web of Science ®Google Scholar
• Uden L, Barber E, Ford N, Cooke GS. Risk of tuberculosis infection and disease for health care workers: an updated meta-analysis. Open Forum Infect Dis. 2017;4(3):ofx137. doi:10.1093/ofid/ofx137.
   PubMed Web of Science ®Google Scholar
• Baussano I, Nunn P, Williams B, Pivetta E, Bugiani M, Scano F. Tuberculosis among health care workers. Emerg Infect Dis. 2011;17(3):488–494. doi:10.3201/eid1703.100947.
   PubMed Web of Science ®Google Scholar
• Sosa LE, Njie GJ, Lobato MN, et al. Tuberculosis screening, testing, and treatment of US health care personnel: recommendations from the National Tuberculosis Controllers Association and CDC, 2019. MMWR Morb Mortal Wkly Rep. 2019;68(19):439–443. doi:10.15585/mmwr.mm6819a3.
   PubMed Web of Science ®Google Scholar
• Lobue P, Menzies D. Treatment of latent tuberculosis infection: an update. Respirology. 2010;15(4):603–622. doi:10.1111/j.1440-1843.2010.01751.x.
   PubMed Web of Science ®Google Scholar
• Horsburgh CR, Jr, Goldberg S, Bethel J, Tuberculosis Epidemiologic Studies Consortium, et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010;137(2):401–409. doi:10.1378/chest.09-0394.
   PubMed Web of Science ®Google Scholar
• Colson P, Hirsch-Moverman Y, Bethel J, Tuberculosis Epidemiologic Studies Consortium, et al. Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada. Int J Tuberc Lung Dis. 2013;17(4):473–479. doi:10.5588/ijtld.12.0697.
   PubMed Web of Science ®Google Scholar
• Lee H, Koo GW, Min J-H, et al. Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay. Sci Rep. 2019;9(1):1–8. doi:10.1038/s41598-018-37319-7.
   PubMed Web of Science ®Google Scholar
• PRISMA. Transparent reporting of systematic reviews and meta-analyses. 2015.
   Google Scholar
• NHLBI. Quality assessment tool for observational cohort and cross-sectional studies. Bethesda: NIH National Heart, Lung, and Blood Institute; 2014.
   Google Scholar
• Chung SJ, Lee H, Koo GW, et al. Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital. Sci Rep. 2020;10(1):1–8. doi:10.1038/s41598-020-63156-8.
   PubMed Web of Science ®Google Scholar
• Han S-S, Lee SJ, Yim J-J, Song JH, Lee EH, Kang YA. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: a multicentre cohort analysis. PLoS One. 2019;14(9):e0222810. doi:10.1371/journal.pone.0222810.
   PubMed Web of Science ®Google Scholar
• Jo K-W, Kim JS, Kwon H-S, et al. Adverse event and treatment completion rates of a 12-dose weekly isoniazid and rifapentine course for South Korean healthcare workers. Respir Med. 2019;158:42–48. doi:10.1016/j.rmed.2019.10.005.
   PubMed Web of Science ®Google Scholar
• Park SY, Lee E, Lee EJ, Kim TH, Kim Y-K. Screening and treatment of latent tuberculosis infection among healthcare workers at a referral hospital in Korea. Infect Chemother. 2019;51(4):355–364. doi:10.3947/ic.2019.51.4.355.
   PubMed Web of Science ®Google Scholar
• Lee EH, Kim S, Ha E, et al. Treatment of latent tuberculous infection among health care workers at a tertiary hospital in Korea. Int J Tuberc Lung Dis. 2018;22(11):1336–1343. doi:10.5588/ijtld.18.0280.
   PubMed Web of Science ®Google Scholar
• Swift MD, Molella RG, Vaughn AI, et al. Determinants of latent tuberculosis treatment acceptance and completion in healthcare personnel. Clin Infect Dis. 2020;71(2):284–290. doi:10.1093/cid/ciz817.
   PubMed Web of Science ®Google Scholar
• Xu Y, Schwartzman K. Referrals for positive tuberculin tests in new health care workers and students: a retrospective cohort study. BMC Public Health. 2010;10(1):28. doi:10.1186/1471-2458-10-28.
   PubMedGoogle Scholar
• Arguello Perez E, Seo SK, Schneider WJ, Eisenstein C, Brown AE. Management of latent tuberculosis infection among healthcare workers: 10-year experience at a single center. Clin Infect Dis. 2017;65(12):2105–2111. doi:10.1093/cid/cix725.
   PubMed Web of Science ®Google Scholar
• WHO. Global tuberculosis report 2019. Geneva: World Health Organization; 2019.
   Google Scholar
• Ahn Y-S, Lim H-S. Occupational infectious diseases among Korean health care workers compensated with Industrial Accident Compensation Insurance from 1998 to 2004. Ind Health. 2008;46(5):448–454. doi:10.2486/indhealth.46.448.
   PubMed Web of Science ®Google Scholar
• Jo K, Woo J, Hong Y, et al. Incidence of tuberculosis among health care workers at a private university hospital in South Korea. Int J Tuberc Lung Dis. 2008;12(4):436–440.
   PubMed Web of Science ®Google Scholar
• Jo K-W, Hong Y, Park JS, et al. Prevalence of latent tuberculosis infection among health care workers in South Korea: a multicenter study. Tuberc Respir Dis (Seoul). 2013;75(1):18–24. doi:10.4046/trd.2013.75.1.18.
   PubMedGoogle Scholar
• Jong Lee K, Ae Kang Y, Mi Kim Y, et al. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay. Scand J Infect Dis. 2010;42(9):672–678. doi:10.3109/00365548.2010.485575.
   PubMed Web of Science ®Google Scholar
• Park HY, Jeon K, Suh GY, et al. Interferon-γ release assay for tuberculosis screening of healthcare workers at a Korean tertiary hospital. Scand J Infect Dis. 2010;42(11–12):943–945. doi:10.3109/00365548.2010.524658.
   PubMed Web of Science ®Google Scholar
• KCDC. 2020 National Tuberculosis Control Guidelines. Korean Centers for Disease Control and Prevention (KCDC); 2020.
   Google Scholar
• Domínguez J, Latorre I, Santin M. Diagnosis and therapeutic approach of latent tuberculosis infection. Enferm Infecc Microbiol Clin. 2018;36(5):302–311. doi:10.1016/j.eimce.2017.11.021.
   Web of Science ®Google Scholar
• Lange C, Mandalakas AM, Kalsdorf B, Denkinger CM, Sester M. Clinical application of interferon-γ release assays for the prevention of tuberculosis in countries with low incidence. Pathog Immun. 2016;1(2):308–329. doi:10.20411/pai.v1i2.173.
   PubMedGoogle Scholar
• Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64(2):e1–e33. doi:10.1093/cid/ciw694.
   PubMed Web of Science ®Google Scholar
• ECDC. Handbook on Tuberculosis Laboratory Diagnostic Methods in the European Union – Updated 2018. Stockholm: ECDC. European Centre for Disease Prevention and Control;2018.
   Google Scholar
• Mok JH. Diagnosis and treatment of latent tuberculosis infection in healthcare workers. Tuberc Respir Dis (Seoul). 2016;79(3):127–133. doi:10.4046/trd.2016.79.3.127.
   PubMed Web of Science ®Google Scholar
• Joshi M, Monson TP, Joshi A, Woods GL. IFN-γ release assay conversions and reversions. Challenges with serial testing in US health care workers. Ann Am Thorac Soc. 2014;11(3):296–302. doi:10.1513/AnnalsATS.201310-378OC.
   PubMedGoogle Scholar
• Jhun BW, Koh W-J. Treatment of isoniazid-resistant pulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2020;83(1):20–30. doi:10.4046/trd.2019.0065.
   PubMed Web of Science ®Google Scholar
• Zenner D, Beer N, Harris RJ, Lipman MC, Stagg HR, van der Werf MJ. Treatment of latent tuberculosis infection: an updated network meta-analysis. Ann Intern Med. 2017;167(4):248–255. doi:10.7326/M17-0609.
   PubMed Web of Science ®Google Scholar
• Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(11):1269–1278. doi:10.1016/S1473-3099(16)30216-X.
   PubMed Web of Science ®Google Scholar
• Pradipta IS, Houtsma D, van Boven JF, Alffenaar J-WC, Hak E. Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. Npj Prim Care Respir Med. 2020;30(1):1–10. doi:10.1038/s41533-020-0179-x.
   PubMed Web of Science ®Google Scholar
• Stuurman AL, Noordegraaf-Schouten MV, van Kessel F, Oordt-Speets AM, Sandgren A, van der Werf MJ. Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review. BMC Infect Dis. 2016;16(1):257. doi:10.1186/s12879-016-1549-4.
   PubMedGoogle Scholar
• Barss L, Moayedi-Nia S, Campbell J, Oxlade O, Menzies D. Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2020;24(1):100–109. doi:10.5588/ijtld.19.0185.
   PubMed Web of Science ®Google Scholar
• Alele FO, Franklin RC, Emeto TI, Leggat P. Occupational tuberculosis in healthcare workers in sub-Saharan Africa: a systematic review. Arch Environ Occup Health. 2019;74(3):95–108. doi:10.1080/19338244.2018.1461600.
   PubMed Web of Science ®Google Scholar